RecruitingNot Applicable

Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)

Malaysia135 participantsStarted 2025-11-04

Plain-language summary

This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts and PWID regarding their experiences with ART. This strategy will then be pilot tested in a randomized controlled trial (Aim 3). The research will not impact the type of medication and dose prescribed, but rather, how soon providers are able to prescribe ART after diagnosis. The focus of this registration is Aim 3.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Be the HIV clinician who prescribes ART for a PWID in one of the selected clinics.
✓. Be willing to use the RS-ART protocol.
✓. Be at least 18 years old. No minors below age 18 will be enrolled in the study.
✓. Provide informed consent.

What they're measuring

HIV Stigma Framework Scale

Timeframe: Baseline and 6 months

Substance Use Mechanism Scale

Timeframe: Baseline and 6 months

Trial details

NCT IDNCT06541028

SponsorYale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-05

Contact for this trial

David Oliveros Gómez, MPH

202-805-8118 david.oliveros@yale.edu

View on ClinicalTrials.gov More Hiv trials